They highlight concerns raised by independent research and member states, and repeat Parliament’s call for an overhaul of the EU’s GMO authorisation procedure.
A resolution opposing the marketing of products containing maize DAS-40278-9 points to concerns raised by independent research about the risks of the 2,4D herbicide, to which the maize is resistant, for embryo development and endocrine disruption.
Member States criticised the authorisation procedure during the three-month consultation period before approval, referring to missing or insufficient data, contradictory statements and poor test design.
The non-binding resolution was adopted with 435 votes to 216 and 34 abstentions.
In a separate resolution, adopted with 425 votes to 230 and 27 abstentions, MEPs say that imports of products from genetically modified cotton GHB119 should not be authorised, as this would encourage the use of glufosinate ammonium-based herbicides (to which GHB119 is resistant) in the world, while glufosinate is classified as toxic for reproduction.
Wednesday May 17, 2017/ European Parliament.